Zobrazeno 1 - 3
of 3
pro vyhledávání: '"59"'
Autor:
Chan Joon Kim, Mahn-Won Park, Min Chul Kim, Eun-Ho Choo, Byung-Hee Hwang, Kwan Yong Lee, Yun Seok Choi, Hee-Yeol Kim, Ki-Dong Yoo, Doo-Soo Jeon, Eun-Seok Shin, Young-Hoon Jeong, Ki-Bae Seung, Myung Ho Jeong, Hyeon Woo Yim, Youngkeun Ahn, Kiyuk Chang, Yong-Hoon Jeong, Myung Ho Jeon, Ju-Hyeon Oh, Sang Jin Ha, Ju Yeol Baek, Kyung Tae Jung, Joon-Hyung Doh, Won Kim, Dong-Bin Kim, Kwang Soo Cha, Myeong-Ho Yoon, Seung-Ho Hur, Seung-Hwan Lee, Byung-Ryul Cho, Jong-Seon Park, Jin Shin Koh, Sang-Hyun Kim, Jang Hyun Cho, Byung Joo Shim, Sang Wook Kim, Jae-Sik Jang, Kee-Sik Kim, Won-Yong Shin, Ki-Chul Sung
Publikováno v:
The Lancet. 398:1305-1316
Summary Background In patients with acute myocardial infarction receiving potent antiplatelet therapy, the bleeding risk remains high during the maintenance phase. We sought data on a uniform unguided de-escalation strategy of dual antiplatelet thera
Autor:
Yasunori Shintani, Masafumi Myoishi, Shigeru Fukuzawa, Masaharu Ishihara, Natsuki Nakamura, Toshimitsu Hamasaki, Masafumi Kitakaze, Kouki Watanabe, Osamu Seguchi, Yoshiyuki Nagai, Kazuo Kimura, Tetsuo Minamino, Soichiro Kitamura, Atsushi Hirayama, Takahiro Ohara, Yoshihiko Saito, Kenshi Fujii, Shinsuke Nanto, Jiyoong Kim, Hitonobu Tomoike, Masanori Asakura, Hiroshi Asanuma
Publikováno v:
The Lancet. 370:1483-1493
Summary Background Patients who have acute myocardial infarction remain at major risk of cardiovascular events. We aimed to assess the effects of either human atrial natriuretic peptide or nicorandil on infarct size and cardiovascular outcome. Method
Autor:
Kenneth Egstrup, Agner E, Lars Køber, Bradley Marchant, Jørgen Videbæk, Carlsen Je, Mogens Møller, Christian Torp-Pedersen, Erik Sandoe, Poul Erik Bloch Thomsen, A. John Camm
Publikováno v:
The Lancet. 356:2052-2058
Summary Background Arrhythmias cause much morbidity and mortality after myocardial infarction, but in previous trials, antiarrhythmic drug therapy has not been convincingly effective. Dofetilide, a new class III agent, was investigated for effects on